Zion Market Research Global Spine Biologics Market, 2016–2024 | Page 3

Spine Biologics Market
Global Spine Biologics Market: Segmentation
The spine biologics market is segmented on the basis of product, surgery, and region. The
product segment is classified into the cell based matrix, spinal allografts, platelet rich
plasma, and bone graft substitutes. The spinal allografts segment is sub-segmented into the
demineralized bone matrix and machined bones allograft. The bone graft substitute is sub-
segmented into synthetic bone grafts and bone morphogenetic proteins. Depending on the
surgery, the market is divided into anterior cervical discectomy and fusion, lateral lumbar
interbody fusion, transforaminal lumbar interbody fusion, anterior lumbar interbody fusion,
and other surgeries. The region wise breakdown of the market includes North America,
Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
Request Report TOC (Table of Contents) @
https://www.zionmarketresearch.com/toc/spine-biologics-market
Global Spine Biologics Market: Regional Analysis
North America contributed the largest market share in the global spine biologics market due
to stable economic growth. North America is followed by Europe. Other factors influencing
the market are an increase in the disposal income, growing population, improved medical
literacy, and raising awareness regarding newly developed technologies. Spine biologics
has a tremendous demand from the regions of America owing to the advancement in the
technology and large pool of the patients. The market in Asia Pacific is experiencing growth
in the market owing to increase in the patient pool, advanced rheumatoid arthritis and
osteoarthritis procedure, availability of the sophisticated diagnostic technique, and growing
awareness among the people. Emerging economies such as China, India, Korea, Thailand,